Cancer Research

The transition of follow-up care from intensive monthly screenings to simple annual questionnaires illustrates the long-term stability achieved by modern transplant survivors. This remarkable shift is personified by Andrew Ruane, whose survival story bridges the primitive era of oncology and the

The initiative led by Professor Mo Maniruzzaman focuses on connecting disparate technological tools into a singular automated production ecosystem. This groundbreaking shift at the University of Mississippi represents a direct response to the stagnant timelines that have historically defined the

Recent research suggests that the prognostic value of the CFH gene may be driven primarily by the FHL-1 isoform rather than the circulating full-length protein. In the rapidly shifting landscape of 2026 oncology, identifying reliable prognostic biomarkers has become the cornerstone of improving

Hyaluronic acid-decorated carriers target the CD44 receptor, which is frequently overexpressed in bladder tumors, to improve the specificity of localized therapy. The staggering incidence of urologic malignancies, which currently accounts for more than 2.6 million new cases and 700,000 deaths

Safety profiles for minibeam radiation show significantly fewer skin injuries and hair loss compared to the side effects observed with traditional wide-field radiation techniques. This clinical advantage marks a pivotal shift in managing primary central nervous system lymphoma, a notoriously

The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long limited the reach of personalized autologous cellular treatments in oncology clinics. While chimeric antigen receptor (CAR) T-cell therapies have established a foundational success in treating